Skip to main content

Regulatory and Washington

  • CVS care-management services subsidiary wins URAC accreditation

    WOONSOCKET, R.I. — Washington-based healthcare accrediting organization URAC has given a subsidiary of CVS Caremark case management accreditation, valid through March 1, 2016, CVS said Wednesday.

    CVS said Accordant Health Services met URAC's standards, which require companies to establish processes to assess, plan and implement case management interventions.

  • Study: Prescription-only PSE legislation carries a significant cost burden

    WASHINGTON — Prescription-only pseudoephedrine laws result in well more than $278 million in additional burdens to taxpayers, according to a study published by Matrix Global Advisors on Monday. 

  • Costco backs minimum wage increase

    WASHINGTON — Club retailer Costco Wholesale is throwing its support behind a bill introduced in Congress Tuesday to raise the federal minimum wage.

  • GPhA defends patent settlements as Supreme Court date nears

    NEW YORK — The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.

    The case, FTC v. Actavis, will go before the high court on March 25 and may decide the future of patent settlements between branded and generic drug companies. The Generic Pharmaceutical Association filed an amicus brief with the court last week defending the settlements as beneficial to consumers.

  • Actavis seeks approval for testosterone-replacement gel

    PARSIPPANY, N.J. — Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

    Actavis, formerly known as Watson Pharmaceuticals, said it had filed a regulatory approval application with the Food and Drug Administration for a generic version of Endo Pharmaceuticals' Fortesta (testosterone) gel in the 10 mg-per-0.5 g strength.

  • Senators encourage GAO to investigate ways to collaborate on prescription drug abuse

    WASHINGTON — Several senators have requested that the Government Accountability Office look for ways to coordinate the efforts of law enforcement and public health agencies at various levels and nonprofit organizations to address prescription drug abuse.

  • Reports: FDA investigating more than two-dozen compounding pharmacies

    NEW YORK — The Food and Drug Administration will inspect about 30 compounding pharmacies that it has deemed "high risk," according to published reports.

    Businessweek reported that the FDA started visits to the pharmacies started last month and would continue for the next two months. So far, unsanitary conditions were found at pharmacies in Chicago, Florida, Arkansas and Mississippi.

  • Sequester will hamper disease-prevention efforts, report warns

    NEW YORK — Automatic spending cuts stemming from the failure of Congress and the White House to reach a budget deal will likely harm the disease-preventing capabilities of the Centers for Disease Control and Prevention, according to a new report.

    GlobalData, a market research and analytics firm, said the slashing of the CDC's funding by $450 million, or 8%, due to the sequester would both hamper its ability to prevent infectious diseases through immunization, surveillance and response programs while also failing to accomplish the goal of decreasing federal spending.

X
This ad will auto-close in 10 seconds